Nanomechanical Testing for Early Breast Lesions
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
Recruiting
N/A
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 2,706 (estimated)
- Sponsor
- ARTIDIS AG · Industry
Who this trial is looking for
This trial is looking for patients with suspicious breast lesions who need a breast biopsy. Participants will have their tissue samples tested to see how well a new measurement method works compared to the standard tests.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I can understand and sign a consent form.
- I have a reason to need a breast biopsy for diagnosis.
- My performance status is between 0 and 3 on the ECOG scale.
You may not be able to join if
- I have a medical condition that the researcher thinks makes me unsuitable for the study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This prospective, blinded, single-arm study aims to test the performance of nanomechanical phenotype in predicting tumor type, tumor aggressiveness, and neoadjuvant treatment response compared to the gold standard of histopathological assessment. The study involves patients with suspicious breast lesions who will undergo a breast biopsy procedure indicated by standard of care. The nanomechanical p…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged ≥ 18 years
* Ability to understand and the willingness to sign a written informed consent.
* Indication for breast biopsy for diagnostic purposes
* ECOG performance status of 0 to 3.
Exclusion Criteria:
* Conditions that, in the investigator's opinion, might in…
Contacts